Price Alert

Entero Therapeutics Inc. (ENTO)

NASDAQ: ENTO · Real-Time Price · USD

2.11

0.28 (15.30%)

At close: Aug 18, 2025, 3:59 PM

2.01

-4.77%

After-hours: Aug 18, 2025, 06:56 PM EDT

15.30% (1D)

Bid	2
Market Cap	10.06M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
EPS (ttm)	-24.2
PE Ratio (ttm)	-0.09
Forward PE	n/a
Analyst	n/a

Ask	2.14
Volume	396,197
Avg. Volume (20D)	2,204,195
Open	1.81
Previous Close	1.83
Day's Range	1.65 - 2.24
52-Week Range	0.75 - 2.78
Beta	0.81

About ENTO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ENTO

Website n/a

Full Company Profile

Why Price Moved

1 week ago

+66.46%

Entero Therapeutics shares are trading higher afte... Unlock content with Pro Subscription

9 months ago

+1.61%

Entero Therapeutics shares are trading lower. The company announced a proposed reverse merger with Journey Therapeutics.

News

4 days ago · newsfilecorp.com

Entero Therapeutics, Inc. Announces Reverse Stock Split

Boca Raton, Florida--(Newsfile Corp. - August 14, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of target...

1 week ago · newsfilecorp.com

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Boca Raton, Florida--(Newsfile Corp. - August 11, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of target...

2 months ago · newsfilecorp.com

FluroTech Ltd. Announces Change in Directors

Calgary, Alberta--(Newsfile Corp. - June 13, 2025) - FluroTech Ltd. (TSXV: TEST.H) ("FluroTech" or the "Company") is pleased to announce that effective June 12, 2025, Eric Corbett has been appointed t...